Defining the interval for monitoring potential adverse events following immunization (AEFIs) after receipt of live viral vectored vaccines

Live viral vectors that express heterologous antigens of the target pathogen are being investigated in the development of novel vaccines against serious infectious agents like HIV and Ebola. As some live recombinant vectored vaccines may be replication-competent, a key challenge is defining the leng...

Descripción completa

Detalles Bibliográficos
Autores principales: Kochhar, Sonali, Excler, Jean-Louis, Bok, Karin, Gurwith, Marc, McNeil, Michael M., Seligman, Stephen J., Khuri-Bulos, Najwa, Klug, Bettina, Laderoute, Marian, Robertson, James S., Singh, Vidisha, Chen, Robert T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535369/
https://www.ncbi.nlm.nih.gov/pubmed/30497831
http://dx.doi.org/10.1016/j.vaccine.2018.08.085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535369/
https://www.ncbi.nlm.nih.gov/pubmed/30497831
http://dx.doi.org/10.1016/j.vaccine.2018.08.085

Ejemplares similares